SHSE:600381 (China)
Â
Class A
Â¥
4.25
-0.11 (-2.52%)
Sep 2
Business Description
Qinghai Spring Medicinal Resources Technology Co Ltd
ISIN : CNE0000017W0
Share Class Description:
SHSE:600381: Class ATotal Employee Number:
134Compare
Compare
Traded in other countries / regions
600381.China Index Membership
SSE Composite Index IPO Date
2001-05-08Description
Qinghai Spring Medicinal Resources Technology Co Ltd is a China-based company that principally engaged in the integrated development, utilization, production, sales, and consulting services of the natural advantageous resources on the Qinghai-Tibet plateau, as well as the development and utilization of other biological resources. The Company's main products are the cordyceps sinensis series products under the Verygrass brand, which includes cordyceps sinensis pure powder tablet, processed cordyceps sinensis, and raw cordyceps sinensis.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 157.09 | |||||
Equity-to-Asset | 0.96 | |||||
Debt-to-EBITDA | -0.02 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 47.37 | |||||
Beneish M-Score | -2.88 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 33.1 | |||||
3-Year EPS without NRI Growth Rate | 41.5 | |||||
3-Year FCF Growth Rate | -3.5 | |||||
3-Year Book Growth Rate | -13.4 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 28.87 | |||||
9-Day RSI | 41.65 | |||||
14-Day RSI | 46.46 | |||||
3-1 Month Momentum % | -35.64 | |||||
6-1 Month Momentum % | 18 | |||||
12-1 Month Momentum % | -32.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 18.69 | |||||
Quick Ratio | 14.47 | |||||
Cash Ratio | 7.67 | |||||
Days Inventory | 301.71 | |||||
Days Sales Outstanding | 79.37 | |||||
Days Payable | 7.4 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 32.62 | |||||
Operating Margin % | -17.78 | |||||
Net Margin % | -26.92 | |||||
EBITDA Margin % | -27.29 | |||||
FCF Margin % | 0.98 | |||||
OCF Margin % | 4.18 | |||||
ROE % | -7.48 | |||||
ROA % | -7.14 | |||||
ROIC % | -5.69 | |||||
3-Year ROIIC % | -24.13 | |||||
ROC (Joel Greenblatt) % | -12.06 | |||||
ROCE % | -7.54 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 7.6 | |||||
PB Ratio | 2.61 | |||||
Price-to-Tangible-Book | 2.78 | |||||
Price-to-Free-Cash-Flow | 151.78 | |||||
Price-to-Operating-Cash-Flow | 96.59 | |||||
EV-to-EBIT | -30.82 | |||||
EV-to-EBITDA | -30.82 | |||||
EV-to-Revenue | 8.41 | |||||
EV-to-FCF | 855.24 | |||||
Price-to-GF-Value | 0.8 | |||||
Price-to-Projected-FCF | 9.88 | |||||
Price-to-Median-PS-Value | 0.65 | |||||
| Price-to-Net-Current-Asset-Value | 4.38 | |||||
| Price-to-Net-Cash | 11.81 | |||||
Earnings Yield (Greenblatt) % | -3.24 | |||||
FCF Yield % | 0.11 | |||||
Forward Rate of Return (Yacktman) % | -39.13 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Qinghai Spring Medicinal Resources Technology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 277.648 | ||
| EPS (TTM) (Â¥) | -0.132 | ||
| Beta | 0.7715 | ||
| 3-Year Sharpe Ratio | -0.14 | ||
| 3-Year Sortino Ratio | -0.22 | ||
| Volatility % | 82.42 | ||
| 14-Day RSI | 46.46 | ||
| 14-Day ATR (Â¥) | 0.267693 | ||
| 20-Day SMA (Â¥) | 4.546 | ||
| 12-1 Month Momentum % | -32.18 | ||
| 52-Week Range (Â¥) | 2.48 - 5.9 | ||
| Shares Outstanding (Mil) | 587.06 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Qinghai Spring Medicinal Resources Technology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Qinghai Spring Medicinal Resources Technology Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| 0.16:1 Stock Split | 2014-06-27 | 13.00 (+0.00%) | ||
| 1.7:1 Stock Split | 2012-05-15 | 32.02 (-0.46%) | ||
| 1.5:1 Stock Split | 2011-08-25 | 27.11 (-4.33%) | ||
| 1.224:1 Stock Split | 2006-11-24 | 5.33 (+0.00%) | ||
| 1.3:1 Stock Split | 2005-05-12 | 5.79 (-2.34%) | ||
| 2:1 Stock Split | 2004-07-19 | 9.06 (+2.89%) |
Show
Entries
Qinghai Spring Medicinal Resources Technology Co Ltd Frequently Asked Questions
What is Qinghai Spring Medicinal Resources Technology Co Ltd(SHSE:600381)'s stock price today?
The current price of SHSE:600381 is ¥4.25. The 52 week high of SHSE:600381 is ¥5.90 and 52 week low is ¥2.48.
When is next earnings date of Qinghai Spring Medicinal Resources Technology Co Ltd(SHSE:600381)?
The next earnings date of Qinghai Spring Medicinal Resources Technology Co Ltd(SHSE:600381) is .
Does Qinghai Spring Medicinal Resources Technology Co Ltd(SHSE:600381) pay dividends? If so, how much?
Qinghai Spring Medicinal Resources Technology Co Ltd(SHSE:600381) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Qinghai Spring Medicinal Resources Technology Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers